Drug Shortage Report for MIRVALA 28

Last updated on 2024-10-18 History
Report ID 235701
Drug Identification Number 02410257
Brand name MIRVALA 28
Common or Proper name MIRVALA
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ETHINYL ESTRADIOL DESOGESTREL
Strength(s) 0.0300MG 0.1500MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 28 BLS
ATC code G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-08-20
Estimated end date 2024-10-25
Actual end date 2024-10-17
Shortage status Resolved
Updated date 2024-10-18
Company comments 21 BLS available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2024-10-18 French Compare
v14 2024-10-18 English Compare
v13 2024-10-10 French Compare
v12 2024-10-10 English Compare
v11 2024-09-20 French Compare
v10 2024-09-20 English Compare
v9 2024-09-12 French Compare
v8 2024-09-12 English Compare
v7 2024-09-06 French Compare
v6 2024-09-06 English Compare
v5 2024-08-30 French Compare
v4 2024-08-30 English Compare
v3 2024-08-22 French Compare
v2 2024-08-22 French Compare
v1 2024-08-22 English Compare

Showing 1 to 15 of 15